Sartorius Group
Annual Report
2024
“For the entire life science industry, 2024 was characterized by a challenging market situation: the pandemic-related destocking at customers, which lasted much longer than expected, the reluctance to invest, and the Chinese market, which remained very weak. Not only, but also in view of these conditions, we are satisfied with the results we achieved. The trend is increasingly positive. Business development in the second half of the year, and especially in the final quarter, confirms our estimate that the temporary weakness in demand is coming to an end and that the industry will gradually return to its robust, structurally underlying growth trend.”
Sales revenue
€3,380.7m
in constant FX: 0.1%
Underlying EBITDA
€945.3m
-1.8%
Order intake
€3,377.5m
in constant FX: 10.8%
Employees
13,528
-1,086
Market capitalization
~€13.4bn
-34.6%
Group Business Development and Divisions
After the very volatile development of previous years due to the pandemic, the business situation at Sartorius stabilized in 2024 despite a difficult environment in the entire life science industry that lasted longer than expected. In particular, the second half of the year and especially the last quarter showed a significant improvement compared to the first half. The trend in the consumables business was increasingly positive, as most customers are reaching their target inventory levels, some of which have been revised downwards several times, and are gradually returning to an order level that corresponds to their production activities.
Bioprocess Solutions
In the Bioprocess Solutions Division, Sartorius offers a broad product portfolio that covers all steps in the production of a biopharmaceutical. The company has held leading market positions for years in its core technologies, such as filtration, fermentation, cell cultivation and fluid management.
Lab Products & Services
The Lab Products & Services Division offers laboratories in the pharmaceutical and biopharmaceutical industries as well as at academic research institutes innovative solutions for bioanalytics, in addition to premium laboratory products, consumables and services. Sartorius is among the market leaders in laboratory balances, pipettes and lab consumables.